[ad_1]
National access to 1.5 million vaccines by the pharmaceutical company Pfizer is expected in the first quarter of 2021.
One batch is expected to arrive in January and another in February, both from Pfizer. Only in mid-January should a decision be made on the final evaluation and acceptance of Moderna’s vaccine.
The coordinator admitted that in January it is also possible to access vaccines from these pharmaceutical companies, warning, however, of certain “uncertainty”: for example, there is still no date for the evaluation of the AstraZeneca vaccine, although there is “hope” that there is a decision. January or February.
“It is the best scenario, but there is still uncertainty, that is, in terms of quantity,” he said.
View or review here, in its entirety, the Great interview with Francisco Ramos.